SLN approach for nose-to-brain delivery of alprazolam

ISSN： 2190-393X

Source： Drug Delivery and Translational Research, Vol.2, Iss.6, 2012-12, pp. : 498-507

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Delivery of Brain-Derived Neurotrophic Factor via Nose-to-Brain Pathway

By Vaka Siva Murthy Sathyanarayana Balaji Anna Repka Michael

Pharmaceutical Research, Vol. 29, Iss. 2, 2012-02 ,pp. : 441-447

Springer Publishing Company

Access to resources Recommend Favorite

Nose-to-brain delivery of TS-002, prostaglandin D2 analogue

By Yamada Kenji Hasegawa Masatoshi Kametani Shunichi Ito Shusei

Journal of Drug Targeting, Vol. 15, Iss. 1, 2007-01 ,pp. : 59-66

Informa Healthcare

Access to resources Recommend Favorite

Nose-to-Brain Drug Delivery by Nanoparticles in the Treatment of Neurological Disorders

Current Medicinal Chemistry, Vol. 21, Iss. 37, 2014-12 ,pp. : 4247-4256

Bentham Science Publishers

Access to resources Recommend Favorite

Solanum tuberosum lectin-conjugated PLGA nanoparticles for nose-to-brain delivery: in vivo and in vitro evaluations

By Chen Jie Zhang Chi Liu Qingfeng Shao Xiayan Feng Chengcheng Shen Yehong Zhang Qizhi Jiang Xinguo

Journal of Drug Targeting, Vol. 20, Iss. 2, 2012-02 ,pp. : 174-184

Informa Healthcare

Access to resources Recommend Favorite

Drug Delivery Systems from Nose to Brain

Current Pharmaceutical Biotechnology, Vol. 13, Iss. 12, 2012-09 ,pp. : 2355-2379

Bentham Science Publishers

Access to resources Recommend Favorite